IM Cannabis (IMCC) Amortizatization of Intangibles (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Amortizatization of Intangibles of $272722.9 for Q1 2026, up 15.78% year-over-year from $235557.8 in Q1 2025, and up 11.7% quarter-over-quarter from $244149.4 in Q3 2025.
IM Cannabis (IMCC) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
IM Cannabis' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $272722.9 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 15.78% year-over-year to $272722.9; the TTM figure through Mar 2026 stood at $981212.9 (up 8.16% YoY), while the FY2024 annual figure was $1.0 million, down 22.81% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $272722.9, up from $244149.4 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $508252.7 in Q2 2022, with the low at $195725.3 in Q3 2024.
- The 5-year median for Amortizatization of Intangibles is $318305.9 (2023), against an average of $318641.4.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles surged 1312.22% in 2022, then slumped 39.12% in 2024.
- IM Cannabis' Amortizatization of Intangibles stood at $374981.8 in 2022, then slipped by 15.97% to $315115.7 in 2023, then fell by 22.53% to $244104.6 in 2024, then increased by 0.02% to $244149.4 in 2025, then gained by 11.7% to $272722.9 in 2026.
- Business Quant data shows IMCC's Amortizatization of Intangibles at $272722.9 in Q1 2026, $244149.4 in Q3 2025, and $228782.9 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272,722.93 |
| Mar 31, 2026 | 272,722.93 |
| Sep 30, 2025 | 244,149.36 |
| Sep 30, 2025 | 244,149.36 |
| Jun 30, 2025 | 228,782.86 |
| Jun 30, 2025 | 228,782.86 |
| Mar 31, 2025 | 235,557.77 |
| Mar 31, 2025 | 235,557.77 |
| Dec 31, 2024 | 244,104.56 |
| Dec 31, 2024 | 244,104.56 |
| Sep 30, 2024 | 195,725.26 |
| Sep 30, 2024 | 195,725.26 |
| Jun 30, 2024 | 231,771.55 |
| Jun 30, 2024 | 231,771.55 |
| Mar 31, 2024 | 335,435.17 |
| Mar 31, 2024 | 335,435.17 |
| Dec 31, 2023 | 315,115.74 |
| Dec 31, 2023 | 315,115.74 |
| Sep 30, 2023 | 321,496.03 |
| Sep 30, 2023 | 321,496.03 |